Active Ingredient: DEXLANSOPRAZOLE
Proprietary Name: DEXLANSOPRAZOLE
Dosage Form; Route of Administration: CAPSULE, DELAYED RELEASE; ORAL
Strength: 30MG
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A205205
Product Number: 001
Approval Date: Jan 19, 2024
Applicant Holder Full Name: MYLAN PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information